The transcription of the insulin-like growth factor 1 (igf-1) gene generates 3 mRNA isoforms, namely the IGF-1Ea, IGF-1Eb and IGF-1Ec (or MGF). Herein we have analyzed the expression of IGF-1 isoforms in eutopic and ectopic endometrium (red lesions and endometriotic cyst) of women with endometriosis and we have characterized the actions of a synthetic MGF E peptide on KLE cells. Our data documented that all 3 igf-1 gene transcripts are expressed in the stromal cells of the eutopic and ectopic endometrium, however, endometriotic cysts contained significantly lower IGF-1 isoforms expression, both at the mRNA and protein level, as it was shown using semi-quantitative PCR and immunohistochemical (IHC) methods. In addition, the glandular cells of the eutopic endometrium did not express any of the IGF-1 isoforms; however, the glandular cells of the ectopic endometrium (red lesions) did express the IGF-1Ec at mRNA and protein level. Furthermore, synthetic MGF E peptide, which comprised the last 24 aa of the MGF, stimulated the growth of the KLE cells. Experimental silencing of the type 1 IGF receptor (IGF-1R) and insulin receptor (IR) expression of KLE cells (siRNA knock out methods) did not alter the mitogenic action of the synthetic MGF E peptide revealing that MGF E peptide stimulates the growth of KLE cells via an IGF-1R-independent and IRindependent mechanism. These data suggest that IGF-1Ec transcript might generate, apart from mature IGF-1 peptide, another post-translational bioactive product which may have an important role in endometriosis pathophysiology.
Introduction
Endometriosis is a common benign gynecological condition that is defined as the presence of endometrial stromal and glandular cells outside the endometrial cavity and has a prevalence of 6-10% in women of reproductive age (1) . This prevalence is approximately 20% in women with infertility (2) . Despite extensive research and numerous theories proposed, the pathogenesis of endometriosis is yet to be determined and several immunological and growth factors have been investigated in the establishment and maintenance of endometriotic lesions.
In addition it has been suggested that ectopic endometrial cells undergo decreased apoptosis compared to eutopic endometrial cells (3) and that insulin-like growth factor 1 (IGF-1) is one of the contributing factors that inhibits apoptosis and acts mitogenically on endometrial cells in vitro (4) . Furthermore, increased levels of IGF-1 have been found in the peritoneal fluid of women with endometriosis compared to controls (5) , which were associated with increased proteolysis of IGF-binding protein 3 (IGFBP-3) mediated by urokinase-type plasminogen activator (uPA) (6, 7).
The igf-1 gene contains 6 exons that in humans give rise to three igf-1 gene transcripts by alternative splicing, namely IGF-1Ea, IGF-1Eb and IGF-1Ec (which has been named also mechano growth factor, MGF). The resulting IGF-1 isoforms undergo post translational cleavage to produce a common biologically active product, namely the mature IGF-1, which is encoded by exons 3 and 4 and it is responsible for the binding with the IGF receptors (IGF-Rs), and different E domain products ( Fig.   1 ), which contain different parts of exons 5 and/or exon 6 (8) (9) (10) (11) and have been proposed to act autonomously (8, 12) .
Insulin-like growth factor 1 mediates its actions through binding to specific receptors, such as the type 1 IGF receptor (IGF-1R), the Insulin Receptor (IR), and Molecular Medicine www.molmed.org
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several atypical receptors such as the hybrid IR/IGF-1R. Type 1 IGF receptor and IR are cell surface heterotetrameric tyrosine kinase receptors which are coupled to intracellular signalling pathways, such as the ras-raf-MAPK-ERKs and PI3K-AKT signalling cascades (13) .
Except for binding IGF-1, IGF-1R can also bind insulin-like growth factor 2 (IGF-2). This is a small peptide that shares approximately 60% of amino acids with IGF-1 and 40% with pro-insulin, and by its binding to IGF-1R, IGF-2 regulates cell proliferation, survival and differentiation. The affinity of IGF-2 for binding IGF-1R is far less than IGF-1 and so it is for insulin (14, 15) . Although IGF-2 can bind all three receptors (IGF-1R, IGF-2R and IR), its mitogenic and metabolic actions are mediated primarily by binding to IGF-1R. In contrast to IGF-1R, IGF-2R is a transmembrane single chain glycoprotein known as the cation-independent mannose-6-phosphate receptor (16) .
The distinctive biological roles of the IGF-1 isoforms and the mechanisms that regulate their expression have not been clearly documented. Several studies have investigated the expression patterns of these IGF-1 transcripts in skeletal muscle (17) (18) (19) and there is a growing interest vis-à-vis the potential role of MGF expression in skeletal and cardiac muscle regeneration and hypertrophy following exercise-induced skeletal muscle damage (20) and myocardial infarction (21, 22) . In addition, we have previously reported preliminary data on the expression of IGF-1 isoforms in endometriosis at mRNA level (23) . However, there is little information regarding the IGF-1Ec (MGF) expression in stromal and glandular epithelium of endometriotic lesions and the characterization of the intracellular signalling of MGF E domain vis-avis IGF-1 signalling in endometrial-like cells (20, 22) .
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Herein, we report that all IGF-1 isoforms are expressed in both eutopic and ectopic endometrium, which is, however, significantly lower in endometriotic cysts as compared with this of either eutopic endometrium or red lesions. In addition, we report for the first time that the glandular cells of eutopic endometrium and endometriotic cysts are deprived of any expression of the IGF-1 isoforms while the glandular cells of red lesions express the IGF-1Ec isoform. Furthermore, our data documented that a synthetic MGF E peptide can stimulate the proliferation of human KLE cells, an endometrial carcinoma cell line with phenotype of endometrial-like cells, via an IGF-1R-independent and IR-independent mechanism. These data suggest that a post-translational bioactive E peptide of the IGF-1Ec isoform may be involved in the pathophysiology of endometriosis. Western blot analysis as previously described (25) . The following primary antibodies were used for the immunodetection of IGF-1Ec (MGF) and IGF-1: MGF, a rabbit anti-human MGF polyclonal antibody (1:10,000 dilution), which was raised against a synthetic peptide corresponding to the last 24 amino acids of the E domain of human MGF (IGF-1Ec) and characterized in our Lab, as has been described elsewhere (22) 
temperature. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as an internal control to correct for potential variation in the protein loading and to normalize the protein measurements on the same immunoblot. Blots were incubated with a mouse monoclonal primary antibody for GAPDH (1:2,000 dilution; Santa Cruz Biotechnology) and with a horseradish peroxidase-conjugated secondary anti-mouse IgG (goat anti-mouse, 1:2,000 dilution; Santa Cruz Biotechnology) and specific band(s) were visualized as described elsewhere (20) . Invitrogen) at 37°C in a humidified atmosphere with 5% CO 2 , with culture media being replaced every 2-3 days. KLE cells were treated with 0.5 ng/ml up to 30 ng/ml of insulin (Novo Nordisk, Denmark), 0.5 ng/ml up to 50 ng/ml of mature IGF-1 peptide (rhIGF-1, Chemicon, Temecula, CA, USA) and with 0.5 ng/ml up to 50 ng/ml of a synthetic MGF peptide [which comprises the last 24 aa of the E domain of human MGF, synthesized and validated as previously described (25) 

Results
The expression of IGF-1 mRNA transcripts were found to be significantly lower in the endometriotic cysts as compared to this of the eutopic endometrium and this of the red lesions, as assessed by semi-quantitative PCR methods (Fig. 2) . Similar patterns of the IGF-1 transcripts translation were also detected in red lesions and endometriotic cysts as compared to eutopic endometrium at the protein level ( (MGF) products at protein level (Fig. 5, panel A and B ).
Since IGF-1 actions can be mediated not only via its high affinity IGF-1R but also via insulin receptors (IR) as well as hybrid IGF-1R/IR, we have experimentally (Fig. 6A,D,G) . Similar results were obtained in the siRNA IGF-1R KLE cells (Fig. 6B,E,F) . Analyses of β-actin (Fig. 6C) and GAPDH expression (not shown) were used as internal controls for normalization in all cases.
Using these KLE transfectans, we were able to show that exogenous IGF-1 and insulin administration did not stimulate the IGF-1R KO and IR KO KLE cells.
Contrary, IGF-1 and insulin stimulated the growth of parental KLE cells (Fig. 7A, B) .
( transcript is expressed both at the mRNA and protein level. This particular IGF-1 transcript has been associated with regeneration mechanisms of skeletal muscle and myocardial cells (20) (21) (22) .
Semi-quantitative analysis of the IGF-1 transcripts expression using PCR methods revealed that endometriotic cysts expressed IGF-1 transcripts at significantly lower level than this of eutopic endometrium and red lesions. These findings were in line with our preliminary data previously published (23) . Our findings could be explained by the fact that even though endometriotic cysts represent a feature of advanced disease, they are characterized by the presence of fibrosis and low levels of active endometriotic tissue. This is consistent with the natural history of the disease during which active endometriotic tissue is substituted by fibrotic tissue accounting for the increased scarring and adhesion formation found in late stages of endometriosis (23) .
This is also consistent with the results of our previous studies where we documented increased expression of other components of the IGF bioregulatory system, which includes IGFs/uPA/Plasmin/IGFBP-3 expression (6, 7, 27) .
In this study, we used specific antibodies to identify the expression of IGF-1 and Further evidence for such autonomous actions of the synthetic MGF E peptide was provided by our recent data which revealed that MGF E peptide activated ERK1/2 phosphorylation but did not activate AKT phosphorylation in skeletal muscle-like and myocardial-like cells (20, 22) . This particular phosphorylation pattern generated by the MGF E peptide is in agreement with the trypan blue exclusion assays in KLE cells, thus suggesting that MGF E peptide activity is via a IGFRs/IRindependent mechanism and via an as yet unidentified molecule.
In conclusion, our data suggest the possible role of IGF-1Ec (MGF) expression in endometriosis. This is supported by the preferential expression of this IGF-1 transcript in glandular epithelial cells in ectopic endometrium only (red lesions). Conceivably, this preferential MGF expression generates post-translational products, IGF-1 and MGF E peptide, the latter being capable of stimulating the proliferation of endometrial-like cells via an IGF-1R-independent, IR-independent and hybrid IGF-1R/IR-independent mechanism. These data suggest that it may be a role for MGF in the pathogenesis of endometriosis, which may be autonomous and independent from the IGF system. possibly mediated via an IGF-1R-independent, IR-independent and hybrid IGF-1R/IR-independent mechanism in KLE endometrial-like cells.
Significantly different from control-siRNA transfected KLE cells *: P < 0.05, **: P < 0.01, ***: P < 0.001. Molecular Medicine
